Renaissance Technologies’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $578M | Sell |
|
|||||
|
2021
Q1 | $509M | Sell |
|
|||||
|
2020
Q4 | $643M | Sell |
|
|||||
|
2020
Q3 | $544M | Buy |
|
|||||
|
2020
Q2 | $503M | Buy |
|
|||||
|
2020
Q1 | $338M | Buy |
|
|||||
|
2019
Q4 | $404M | Buy |
|
|||||
|
2019
Q3 | $279M | Buy |
|
|||||
|
2019
Q2 | $215M | Buy |
|
|||||
|
2019
Q1 | $108M | Buy |
|
|||||
|
2018
Q4 | $37.1M | Buy |
|
|||||
|
2018
Q3 | $9.44M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $21.4M | Sell |
|
|||||
|
2017
Q3 | $62M | Buy |
|
|||||
|
2017
Q2 | $25.8M | Sell |
|
|||||
|
2017
Q1 | $43.8M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $108M | Buy |
|
|||||
|
2015
Q2 | $2.43M | Sell |
|
|||||
|
2015
Q1 | $54.4M | Buy |
|
|||||
|
2014
Q4 | $28.2M | Sell |
|
|||||
|
2014
Q3 | $34.2M | Sell |
|
|||||
|
2014
Q2 | $38.4M | Buy |
|